Russia’s Enteromix Cancer Vaccine Achieves 100% Success Rate in Clinical Trials

Enteromix, an innovative mRNA-based cancer vaccine developed in Russia, has shown complete efficacy and safety in trials. Awaiting approval from the Ministry of Health, it could soon be available for…

Read more